Cat. No. 1236
Chemical Name: 1,4-Dihydroxy-2,5-di-tert-butylbenz
Biological ActivityA selective inhibitor of endoplasmic reticulum Ca2+-ATPase.
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Certificate of Analysis / Safety Data Sheet
Hassessian et al (1994) Blockade of the inward rectifier potassium current by the Ca2+-ATPase inhibitor 2',5'-di(tert-butyl)-1,4-benzohydroquinone (BHQ). Br.J.Pharmacol. 112 1118. PMID: 7952872.
Dettbarn and Palade (1999) Effects of three sarcoplasmic/endoplasmic Ca++ pump inhibitors on release channels and intracellular stores. J.Pharmacol.Exp.Ther. 285 739. PMID: 9580621.
Fusi et al (1999) 2,5-Di-t-butyl-1,4 benzohydroquinone induces endothelium-dependent relaxation of rat thoracic aorta. Eur.J.Pharmacol. 366 181. PMID: 10082199.
Jan et al (1999) Mechanism of rise and decay of 2,5-di-tert-butylhydroquinone-induced Ca2+ signals in Madin Darby canine kidney cells. Eur.J.Pharmacol. 365 111. PMID: 9988129.
If you know of a relevant citation for this product please let us know.
View Related Products by Product Action
Keywords: BHQ, supplier, Inhibitors, SERCA, ATPase, Ca2+, modulators, Ca2+-ATPase, Signaling, Signalling, Calcium, P-Type, ATPases, Calcium-ATPase, Ion, Transporters, Pumps, Tocris Bioscience, Ca2+-ATPase Inhibitors
Find multiple products by catalog number
March 19 - 23, 2016
Denver, CO, USA